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The aim of the study was to investigate the role of a microenvironment in the induction of epithelial-to-mesenchymal transition
(EMT) as a sign of early stages of carcinogenesis in human lung epithelial cell lines after protracted low-dose rate γ-radiation
exposures. BEAS-2B and HBEC-3KT lung cell lines were irradiated with low-dose rate γ-rays (137Cs, 1.4 or 14mGy/h) to 0.1 or
1Gy with or without adding TGF-β. TGF-β-treated samples were applied as positive EMT controls and tested in parallel to ﬁnd
out if the radiation has a potentiating eﬀect on the EMT induction. To evaluate the eﬀect of the stromal component, the
epithelial cells were irradiated in cocultures with stromal MRC-9 lung ﬁbroblasts. On day 3 post treatment, the EMT markers:
α-SMA, vimentin, ﬁbronectin, and E-cadherin, were analyzed. The oxidative stress levels were evaluated by 8-oxo-dG analysis in
both epithelial and ﬁbroblast cells. The protracted exposure to low Linear Energy Transfer (LET) radiation at the total absorbed
dose of 1Gy was able to induce changes suggestive of EMT. The results show that the presence of the stromal component and
its signaling (TGF-β) in the cocultures enhances the EMT. Radiation had a minor cumulative eﬀect on the TGF-β-induced
EMT with both doses. The oxidative stress levels were higher than the background in both epithelial and stromal cells post
chronic irradiation (0.1 and 1Gy); as for the BEAS-2B cell line, the increase was statistically signiﬁcant. We suggest that the
induction of EMT in bronchial epithelial cells by radiation requires more than single acute exposure and the presence of stromal
component might enhance the eﬀect through free radical production and accumulation.
1. Introduction
Ionizing radiation has been pointed out as the second leading
cause for lung cancer after smoking [1]. However, there are
no detailed mechanistic models for the early stages of
radiation-induced lung carcinogenesis so far.
Over the last ﬁfteen years, the important role of the tissue
microenvironment (stroma) for the early stages of carcino-
genesis and particularly the role of microenvironment in
radiation-induced breast cancer have been highlighted
[2–5]. The stroma of the tissue provides the “soil” for
the transformed cells to grow and invade distant from
their origin causing metastasis. It also produces speciﬁc
chemokines and signaling molecules such as transforming
growth factor beta (TGF-β), epidermal growth factor
(EGF), and hepatocyte growth factor (HGF) during
tumorigenesis [2, 3].
An important step during the modiﬁcation of the micro-
environment is the induction of morphological and
functional changes of the normal stromal ﬁbroblasts. These
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activated growth factor- and chemokine-secreting ﬁbroblast
cells are very often associated with the tumor microenviron-
ment and are thus called cancer-associated ﬁbroblasts
(CAFs) [6, 7]. They are considered to be able to induce tumor
growth and dissemination via secretion of diﬀerent factors,
stimulate angiogenesis, and interact with the tumors’ growth
factor receptors. CAFs have a set of common characteristics
that allows for easy distinguishing from normal ﬁbroblasts.
The majority of these CAF markers have been identiﬁed as
various tropic molecules and extracellular matrix remodeling
enzymes: alpha-smooth muscle actin (α-SMA), matrix
metalloproteinase-1 (MMP1), matrix metalloproteinase-3
(MMP3), and collagens [8, 9]. The expression of some myo-
ﬁbroblast markers, such as α-SMA, can be used as predictive
markers for cancer recurrence and distant metastasis [7].
In the last decades, a process taking part in the epithe-
lial cells has been described—epithelial-to-mesenchymal
transition (EMT) [10–12]. It has a role not only in organo-
genesis and wound healing but also in disease pathogenesis
like ﬁbrosis and cancer. During EMT under microenviron-
mental stimulation, the epithelial cells change their shape
and lose their polarity as well as expression of epithelial
markers. At the same time, they acquire a spindle-shaped
mesenchymal phenotype and gain expression of mesen-
chymal markers [13].
One of the important pathways shared by EMT and
tumorigenesis is the activation of the TGF-β signaling
pathway [11–14]. The TGF-β molecule aﬀects the tumor
microenvironment as it decreases the levels of active
immune system cells, increases angiogenesis, and facilitates
invasion by enhancing the cellular protease activity and
the production of extracellular matrix components by the
tumor microenvironment cells. It is interesting from the
radiation point of view that the TGF-β pathway is induced
by oxidative stress, which is one of the main cell-damaging
conditions produced by low LET radiation [15] particu-
larly at a low-dose rate [16]. The connection between
oxidative stress, TGF-β signaling, and the role of the
microenvironment in radiation-induced cancer has been
studied in detail for breast models [4, 5, 17]. It was also
proven that low dose and low-dose rate gamma radiation
at mGy/h range induces oxidative stress by increasing
the endogenous production of reactive oxygen species in
primary human ﬁbroblast cells (VH10), whole blood sam-
ples, and human lymphocytes [18]. Exposure to ionizing
radiation (IR) is regarded as a sensitizing factor for cells
to undergo TGF-β-induced EMT. Andarawewa et al. [19,
20] showed that a single exposure to IR sensitizes cells
to TGF-β-mediated EMT. Neither radiation nor a chronic
TGF-β secretion alone could induce EMT [19–22].
Radiation-induced secretion of TGF-β, not from the
epithelial cells themselves, but from the surrounding
stroma may increase the occurrence of EMT, which could
be one of the early stages in the radiation-activated
tumorigenic changes [23].
The latent TGF-β activation due to reactive oxygen
species (ROS) is so eﬃcient that it can be used as a sensor
for the oxidative stress [17]. TGF-β is also upregulated in a
NSCLC (non-small-cell lung cancer) patient’s blood samples
during radiotherapy [24]. The high TGF-β levels have been
connected not only with severe late eﬀects but also with
insuﬃcient response to radiotherapy. The TGF-β signaling
pathway has been known for many years to be involved in
the tissue remodeling and induction of late eﬀects of radio-
therapy in the lung, as it has been considered one of the main
mediators of tissue ﬁbrosis in the organ [12, 25].
In this pilot project, we tested the hypothesis that
radiation modiﬁes the lung stromal cells, thus creating an
environment that facilitates EMT and promotes tumorigene-
sis. Our aim was to investigate the role of the microenviron-
ment in the induction of EMT in human lung epithelial cells
after protracted low-dose rate γ-ray exposures, which so far
has not been explored. Such type of protracted radiation
exposures with low-dose rates could occur in real life for
example to workers at uraniummines or to individuals living
in near proximity of contaminated areas [26–28]. To our
knowledge, this is the ﬁrst of its kind study of lung epithelial
cells and the questions we address need further and more
detailed investigation in the future to reveal the mechanisms
of radiation-induced lung carcinogenesis.
2. Materials and Methods
2.1. Cell Culture. The human bronchial epithelial cell line
BEAS-2B was purchased from the American Type Culture
Collection (ATCC, Manassas, VA, USA) and maintained in
serum-free Bronchial Epithelial Cell Growth Medium
(BEGM) medium (Lonza, Walkersville, MD, USA),
supplemented with Bronchial Epithelial Cell Growth
Medium SingleQuots™ Supplements and Growth Factors
(Lonza). The HBEC-3KT bronchial epithelial cell line was
kindly provided by Professor Jerry Shay (UT Southwestern,
TX, USA). The cells were immortalized in the laboratory
of Prof. Shay and further cultured as described by
Ramirez et al. [29]. In brief, the cells were cultured in
KSF (Keratinocyte Serum-Free) media (Gibco, Carlsbad,
CA, USA) supplemented with epidermal growth factor
1-53 (EGF 1-53) and Bovine Pituitary Extract (BPE)
provided frozen from the manufacturer. The MRC-9 nor-
mal human lung ﬁbroblasts were purchased from the
ATTC. The cells were expanded and maintained in
Eagle’s Minimum Essential Medium (Sigma-Aldrich, St.
Louise, MO, USA) supplemented with fetal bovine serum
and L-glutamine as instructed by the supplier.
The cells were stimulated with 0.1-0.2 ng/ml
recombinant human TGF-β1 (#240-B-002, R&D Systems,
Minneapolis, USA).
2.2. Coculturing of the Cells. For the coculture experiments,
1 × 104 BEAS-2B or HBEC-3KT cells were plated on
0.42 cm2 polycarbonate membrane inserts with a 0.4 μm
pore size (Nunc, Thermo Fisher Scientiﬁc, Waltham,
MA, USA) and placed into 35mm plastic petri dishes
(Corning, Tewksbury, MA, USA). For the coculturing,
1 × 105 MRC-9 normal human lung ﬁbroblasts were
plated on the bottom of the 35mm plastic petri dishes, and
the standing inserts, containing BEAS-2B or HBEC-3KT
epithelial cells, were placed into the p35 dishes. The
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cocultures were maintained in ALI (Air-Liquid Interface)
media consisting of 1 : 1 KSF and DMEM supplemented
with 10% FCS and further modiﬁed as described in [30].
The incubation time before analysis was three days.
2.3. Irradiation. The chronic exposures (1.4 or 14mGy/h)
were implemented in a sterile cell culture incubator
(Sanyo, Japan) equipped with a 137Cs source at the Centre
for Radiation Protection Research, The Wenner-Gren
Institute, Stockholm University. The total doses applied
were 0.1Gy (1.4mGy/h) and 1Gy (14mGy/h) as both
took 72hrs. A separate Sanyo incubator was used for
nonexposed cells. Three biological replicates were collected
from each dose and treatment. The experiments were
repeated two or three times as noted in the ﬁgure legends.
2.4. Immunoﬂuorescence Staining. The cells were plated on
membrane inserts on the starting day of the irradiation
and cultured for three days until the cumulated dose
reached 0.1 or 1Gy. The cells were ﬁxed with 4% parafor-
maldehyde for 20min at room temperature (RT). The
blocking was done with 5% FCS (GIBCO) and 0.3%
Triton X-100 (Sigma-Aldrich) in PBS at RT for 30min.
The primary antibodies were added to the cells diluted
in 1% FCS in 0.3% Triton-X-100-PBS: anti-vimentin
(monoclonal mouse anti-human #V6630, Sigma-Aldrich)
1 : 200 for 1 h at RT; anti-E-cadherin 1 : 100 (monoclonal
rabbit anti-human #3195, Cell Signaling, Denver, MA,
USA) for overnight at 4°C; and anti-ﬁbronectin 1 : 20
(polyclonal sheep anti-human #AF1918, R&D Systems,
Minneapolis, MN, USA), again overnight at 4°C. The incu-
bation with secondary Alexa-488-conjugated antibodies
(Invitrogen, Carlsbad, CA, USA) was performed for 1 h
at room temperature. The cells were mounted with propi-
dium iodide containing antifading media Vectashield
(Vector Laboratories, Burlingame, CA, USA). Imaging
was performed with a Zeiss AxioImager Z1 ﬂuorescence
microscope using AxioVision image analysis software
(Carl Zeiss, Göttingen, Germany). The EMT status of the
immunoﬂuorescence images was evaluated via blind
scoring from two independent researchers following clear
scoring criteria and TGF-β-treated samples as positive
controls. The criteria for EMT-positive were increase in
cell size and cell elongation, combined with (1) relocaliza-
tion of vimentin (BEAS-2B cells) or (2) loss of E-cadherin
(HBEC-3KT). The results from the blind scoring were
combined and reported. For the cell size measurements,
we used the manual cell analysis tool from the ImageJ
1.04 (National Institutes of Health, Bethesda, MD, USA,
http://imagej.nih.gov/ij/, 1997-2016) software. Brieﬂy, the
cells were marked manually and included in the Region
Of Interest (ROI) tool. The measure function from the
ROI menu was used to create a table including the area
information of each cell. One hundred cells were analyzed
from each condition.
2.5. Western Blotting. On day 3 after the irradiation onset
when the planned dose (0.1 or 1Gy) has been cumulated,
the cells were lysed in buﬀer containing 8M Urea, 1M Thio-
urea, 30mM Tris, 4% Chaps buﬀer 1% protease inhibitor
cocktail (Roche, Mannheim, Germany), and 1% phosphatase
inhibitor mixture (Protein phosphatase inhibitor cocktail 2
and 3, Sigma-Aldrich). 10 μg of the protein solution was
loaded per lane on 4-12% Bis-Tris Amersham precast gels
(GE Healthcare Bio-Sciences, Uppsala, Sweden). The
separated proteins were transferred onto a PVDF membrane
(Bio-Rad Laboratories, Hertfordshire, UK). After incubating
with the blocking buﬀer (5% skimmed milk, 0.5% Tween-20
in PBS or 5% BSA in 0.75% PBS-Tween-20) for 1 h at RT, the
membranes were blotted with antibodies against ﬁbronectin
(polyclonal sheep anti-human #AF1918, R&D Systems)
1 : 30 000; E-cadherin (monoclonal rabbit anti-human
#3195, Cell Signaling) 1 : 5 000; α-SMA 1 : 5 000 (monoclonal
mouse anti-human #A5228, Sigma-Aldrich); TGF-β1
1 : 5000 (polyclonal rabbit anti-human #NB100-91995,
Novus Biologicals, Littleton, CO, USA); and GAPDH 1 : 50
000 (monoclonal mouse anti-human #G8795, Sigma-
Aldrich) overnight at 4°C. The blots were incubated with
secondary HRP-conjugated antibodies (GE Healthcare) for
1 h at room temperature followed by treatment with Super-
Signal ECL (Thermo Fisher Scientiﬁc, Rockford, IL, USA)
and developed on an X-ray sensitive ﬁlm (GE Healthcare,
Buckinghamshire, UK). Protein expression was quantiﬁed
using the semiquantitative gel analysis function of the
ImageJ 1.04 (National Institutes of Health, Bethesda,
MD, USA, http://imagej.nih.gov/ij/, 1997-2016) software.
The results of each individual protein were normalized to
the GAPDH expression.
2.6. 8-oxo-dG Analysis. For the 8-oxo-dG analysis, medium
was collected simultaneously with cell harvesting and kept
frozen at -20°C. The 8-oxo-dG was measured using a
modiﬁed ELISA assay as described previously [31, 32]. The
ELISA kit was provided by Health Biomarkers Sweden AB.
Brieﬂy, 1ml medium was ﬁltered once using a C18 solid
phase extraction column (Varian, CA) as described
previously [33]. This step is necessary to remove any prod-
ucts other than the 8-oxo-dG that could cross-react with
the monoclonal antibody that was used in ELISA. The
puriﬁed samples were freeze-dried and reconstituted in
PBS. 90 μl of the puriﬁed sample was mixed with 50 μl of a
primary antibody against 8-oxo-dG (Japan Institute for the
Control of Aging, Japan) and transferred to a 96-well ELISA
plate precoated with 8-oxo-dG. After overnight incubation at
4°C, the plates were washed three times with 250 μl of
washing solution. 140 μl of HRP-conjugated secondary
antibody (goat anti-mouse IgG-HRP, Scandinavian
Diagnostic Services, Sweden) was added to each well and
incubated for 2 hours at room temperature. The wells were
washed three times with 250 μl of washing solution and
ﬁnally with PBS (pH7.4). Then, 140 μl of tetramethylbenzi-
dine liquid substrate (ICN Biomedicals Inc., USA) was added
to each well, and the plate was incubated for 15min at room
temperature. The reaction was terminated by adding 70 μl of
2M H3PO4 (Merck, Germany). The absorbance was read at
450 nm using an automatic ELISA plate reader (UV-160A,
Shimadzu, Kyoto, Japan). Each sample was analyzed in
triplicate (variation = 2 5%), and the samples of each
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experiment were analyzed using the same 96-well ELISA
plate. A standard curve for 8-oxo-dG (0.05-10 ng/ml) was
established for each plate covering the range of 8-oxo-dG
in the samples. The validation of the modiﬁed ELISA
method was performed by HPLC-EC (r2: 0.87, p < 0 05)
as described previously [32]. The comparisons between
the ELISA and the HPLC-EC methods showed a linear
correlation at the concentration range found in the human
blood serum [32]. There was no correlation between the
ELISA and the HPLC-EC results when unﬁltered samples
were used.
2.7. Statistical Analysis. Diﬀerences between groups were
analyzed using paired two-sample Student’s t-test, part of
Excel, MS Oﬃce 2003 package, with nonequal assumption
of variances or with one-way ANOVA, and Tukey’s posttest,
part of the statistical package of GraphPad Prism 4 (Graph-
Pad, La Jolla, USA) as noted in the text.
3. Results
3.1. Protracted γ-Radiation with a Dose Rate of 14mGy/h
(1Gy Total Dose) Induces Changes Connected with EMT in
BEAS-2B and HBEC-3KT Bronchial Epithelial Cell Lines. A
low-dose rate irradiation facility was used to perform a series
of protracted irradiation experiments with two bronchial
epithelial cell lines (BEAS-2B and HBEC-3KT). The cells
were plated on membrane inserts and exposed to either 1.4
or 14mGy/h up to 0.1 or 1Gy cumulated doses, respectively,
over a time period of three days as described in Materials and
Methods. The cell lines were immunostained for vimentin
(BEAS-2B) and E-cadherin (HBEC-3KT). These markers
were selected after the two lines were screened for sensitiv-
ity to EMT-inducing stimuli and EMT marker expression
levels [34]. BEAS-2B cells showed signiﬁcant changes in
vimentin expression and HBEC-3KT in E-cadherin
expression, and these two markers were used in [34] and
further as the most sensitive.
After exposure to protracted irradiation, we observed
EMT-related changes (while vimentin levels increase and
extend throughout the cytoplasm relative to control, the E-
cadherin decreases at the plasma membrane relative to
control) in both cell lines after treatment with a dose rate of
14mGy/h and a total dose of 1Gy (Figure 1). No EMT and
change in the cell size were seen after treatment with
1.4mGy/h (0.1Gy total dose). With the higher applied dose
(1Gy), we observed both EMT and a statistically signiﬁcant
increase in the cell size compared to the control. The results
show that the mesenchymal marker vimentin was relocalized
in BEAS-2B cells undergoing EMT (Figure 1(a)). In the
nontreated BEAS-2B cells, vimentin was forming a dense
spot in the cytoplasm, while in the cells that had undergone
EMT-consistent changes, vimentin was forming a ﬁne
intermediate ﬁlament network. The BEAS-2B cells changed
from an epithelial cuboidal morphology to the elongated
form of mesenchymal cells. Interestingly, the cells were
exhibiting long cytoplasmic protrusions post irradiation
(Figure 1(a), blue arrows). The right panels in Figure 1(a)
visualise the changes in cell size and shape during the
EMT process in BEAS-2B cells. The inserts have the same
size; however, in EMT-positive ﬁelds 2, 3, and 4, they con-
tain fewer but larger cells with an elongated shape. We
have performed measurements of the elongation of the
cells (Suppl. Fig 1). The white arrows show the level of
cells which undergone EMT changes in each panel. The
areas were selected to represent EMT negative control,
positive control (TGF-β), irradiated only cells (EMT-posi-
tive), and irradiated plus TGF-β-treated cells (EMT-posi-
tive). When the cell area of the BEAS-2B cells was
measured, there was a statistically signiﬁcant increase in
the size post 1Gy compared to the nontreated controls
(Figure 1(c), BEAS-2B graph).
In HBEC-3KT cells, the epithelial marker E-cadherin was
decreasing in the cell-to cell-contacts in some, but not all
cells. In addition, we observed changes in the cell size in the
HBEC-3KT cells as marked in the right side panels con-
taining again the same size insets (Figure 1(b), 1–4). At
conﬂuence before the exposure, the cells were small with
cobblestone epithelial morphology (Figure 1(b), “No
EMT” panels), while after irradiations, they had grown to
large (Figure 1(b), “EMT” panels, white arrows) cells.
The enlarged areas help to compare the cell size and shape
changes between the control (Figure 1(b), 1) and 1Gy
irradiated cells (Figure 1(b), 4). We also performed the
measurement of the cell size for the HBEC-3KT cells
(Figure 1(c), HBEC-3KT graph). The results were similar
as for the BEAS-2B, there are no increase of the size at
0.1Gy and statistically signiﬁcant increase at 1Gy,
compared to the control.
In addition to chronic irradiation, we treated the
cells with a minimal EMT-inducing concentration of
TGF-β (0.1-0.2 ng/ml) and the same protracted doses
of ionizing radiation at dose rates of 1.4 and 14mGy/h
(total dose 0.1 and 1Gy, respectively) (Figures 1(a) and
1(b), lower images). In this experimental setup, where we
investigated the potentiating eﬀect of radiation on TGF-β-
induced EMT, a statistically signiﬁcant additive eﬀect was
observed only with 1Gy radiation for the BEAS-2B cells
(Figure 1(c)).
While the eﬀect of irradiation on the expression and
relocalization of the EMT markers was clear when
detected by immunoﬂuorescence, western blotting and
semiquantitative evaluation show signiﬁcant changes to
the control only at 0.1Gy in BEAS-2B cells and 0.1Gy
+TGF-β treatments for the ﬁbronectin marker (Figure 2)
for both cell lines. Vimentin is a good marker for immu-
noﬂuorescence studies but not expected to be quantitative
for western blots because the concentration of the vimen-
tin protein is not changed, rather distribution within the
cytoplasm is more diﬀused during EMT. That is why we
have compared only E-cadherin and ﬁbronectin in the
western blots.
Although the analysis failed to show a statistical signif-
icance in the majority of the western blot analyses (except
BEAS-2B 0.1Gy and 0.1Gy+TGF-β and HBEC-3KT
0.1Gy+TGF-β for ﬁbronectin), a trend characteristic for
EMT (increase of ﬁbronectin and decrease of E-cadherin
levels) and also enhancement of the TGF-β-induced
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Figure 1: Immunoﬂuorescence staining of EMTmarker expression in lung epithelial cell lines: (a) in BEAS-2B with vimentin staining and (b)
in HBEC-3KT with E-cadherin staining. The cells were exposed to 0.1 or 1Gy protracted radiation at a dose rate of 1.4 or 14mGy/h, upper
panels. Lower panels: positive TGF-β control and EMT enhancement after combined treatment of the cells with TGF-β and 0.1 or 1Gy of
protracted radiation. Vimentin and E-cadherin are stained in green. The nuclei are counterstained with propidium iodide (red). White
arrows indicate cells with changes consistent with EMT. Cytoplasmic protrusions are marked with blue arrows. The enlarged same size
areas on the right side of (a) for vimentin and (b) for E-cadherin. Numbers 1-4 are visualising the change in cell shape and size: (1)
control, (2) TGF-β, (3) TGF-β+0.1Gy, and (4) 1Gy. Scale bars: 20 μm. (c) ImageJ measurements of the cell size in the BEAS-2B and
HBEC-3KT cells from the image series (a, b). ∗p < 0 05 and ∗∗∗p < 0 001; one-way ANOVA and Tukey’s posttest (n = 3).
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Figure 2: Continued.
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Figure 2: Western blotting analyses of EMT marker expression (a, b) in BEAS-2B and (c, d) HBEC-3KT cells chronically irradiated to a total
dose of (a, c) 0.1 (at 1.4mGy/h) or (b, d) 1Gy (at 14mGy/h). Representative western blot analyses of ﬁbronectin expression (a–d, left side
blots) and E-cadherin expression (a–d, right side blots). The graphs below are results of quantiﬁcation of the protein expression as
described in Materials and Methods. Error bars—standard deviation, comparison to untreated control. ∗∗p < 0 01, one-way ANOVA and
Tukey’s posttest (n = 3).
7Oxidative Medicine and Cellular Longevity
EMT in combination with the IR (Figure 2) were
observed in the HBEC-3KT cells. The other cell line
BEAS-2B responded with EMT characteristic changes
in the ﬁbronectin and E-cadherin only to TGF-β±
irradiation.
3.2. Eﬀect of the Microenvironment on EMT Characteristic
Changes in Fibroblast-Epithelial Cell Cocultures. The
microenvironment is involved in the TGF-β-induced EMT
process via secretion of signaling molecules from the stromal
cells [35, 36]. We observed that TGF-β induces higher
expression of α-SMA, an actin isoform involved in the
formation of stress ﬁbers during myoﬁbroblastic diﬀerentia-
tion in MRC-9 cells (Figure 3) [7, 11]. There is also a trend
in increased α-SMA with 1Gy ionizing radiation in the
MRC-9 cells.
As shown in Figure 3(a), a dose of 0.1Gy delivered at
1.4mGy/h was able to increase slightly the α-SMA expres-
sion. The 1Gy exposures induced a higher level of the stress
ﬁber protein in comparison to the 0.1Gy (Figure 3). The
combination of TGF-β treatment and 1Gy radiation
exposure had some cumulative eﬀects on the α-SMA
expression compared to the TGF-β only. However, we
have to point that we could not show a statistically signif-
icant increase of the radiation and TGF-β eﬀects in
comparison to the TGF-β treatments alone (Figure 3).
In coculturing experiments the epithelial (BEAS-2B or
HBEC-3KT) cells were plated in membrane inserts while
the stromal cells were plated in 35mm Petri dishes. The
cocultures were either sham irradiated or exposed to the
same cumulative doses of 0.1 and 1Gy at 1.4 or 14mGy/h,
respectively. To test if the coculture ALI medium that
contains 5% fetal calf serum (potentially containing minimal
quantities of TGF-β) induces the EMT changes in the epithe-
lial cells, we had a parallel negative control where the cells
were incubated in the ALI medium without a coculture with
the MRC-9 ﬁbroblast. As shown in Suppl. Fig 2, the ALI
medium was not able to induce the EMT. At the same time,
the coculture and the same exposure time of 14mGy/h irra-
diation had a higher EMT-inducing eﬀect than radiation only
(Figures 1 and 4).
In the BEAS-2B cells, enhanced EMT characteristic
changes were detected when the cells were cocultured with
ﬁbroblasts and irradiated with a dose rate of 14mGy/h up
to a cumulative dose of 1Gy, in comparison to those irradi-
ated with a dose rate 1.4mGy/h to a dose of 0.1Gy over the
same time period (Figure 4(a)). With the HBEC-3KT cells,
coculturing with ﬁbroblasts enhanced radiation and the
TGF-β-induced EMT-speciﬁc changes with a dose of 1Gy
(Figure 4(b)). Interestingly, the features of the cocultured
cells undergoing EMT-like transformation, for both BEAS-
2B and HBEC-3KT, are diﬀerent than those of the
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Figure 3: Myoﬁbroblastic marker α-SMA expression in MRC-9 ﬁbroblasts post chronic low LET irradiation at dose rates of (a) 1.4mGy/h to
0.1Gy or (b) 14mGy/h to 1Gy with or without TGF-β. The graphs below are the results of the semiquantiﬁcation of the protein expression as
described inMaterials andMethods. Error bars—standard deviation. ∗p < 0 05 and ∗∗p < 0 01; one-way ANOVA and Tukey’s posttest (n = 3).
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Figure 4: Immunoﬂuorescence staining of EMT marker expression in lung epithelial cell lines cocultured with MRC-9 ﬁbroblasts: (a)
vimentin in BEAS-2B and (b) E-cadherin in HBEC-3KT. The cocultures were exposed to 0.1 or 1Gy of protracted radiation at the dose
rates of 1.4 or 14mGy/h, upper panels. Lower panels: positive control TGF-β treatment and the EMT enhancement after the combined
treatment of the TGF-β+0.1 cells or 1Gy of protracted radiation. Vimentin and E-cadherin are stained in green. The nuclei are
counterstained with propidium iodide (red). White arrows indicate the cells with consistent changes. Scale bars: 20 μm. The enlarged
same size areas on the right side of (a) for vimentin and (b) for E-cadherin with numbers 1-4 are visualising the change in cell shape and
size: (1) control, (2) TGF-β, (3) 1 Gy, and (4) TGF-β+1Gy. (c) ImageJ measurements of the cell size in the BEAS-2B and HBEC-3KT cells
from the image series (a, b). ∗p < 0 05, ∗∗p < 0 01, and ∗∗∗p < 0 001; one-way ANOVA and Tukey’s posttest (n = 3).
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monocultures (Figure 4 and Suppl. Fig 3). As could be seen in
Figure 4 and the insets (Figures 4(a) and 4(b), 3 and 4), the
irradiated and TGF-β-treated cells are both larger than con-
trol and compared to the TGF-β only (Figure 4(c)), and for
the HBEC-3KT (Figure 4(b), 3 and 4), they are containing
more than one nucleus (Figure 4(b)).
3.3. 8-oxo-dG Production from MRC-9, BEAS-2B, and
HBEC-3KT Cells. Radiation-induced oxidative stress is
one of the main cell-damaging conditions induced by
low LET radiation such as X- or γ-rays. The reactive oxy-
gen species generated during the exposure to radiation in
aqueous solutions are able to damage biological mole-
cules, including DNA and cytoplasmic DNA precursors
(dNTP). One of the products from the oxidation of the
deoxyribonucleotides, 8-oxo-dG, has proved to accumu-
late after irradiation. Radiation-induced extracellular 8-
oxo-dG has been reported even after very low dose and
low-dose rate exposures [18, 31]. In our study, chronic
irradiation causes the increase of 8-oxo-dG from the
MRC-9 ﬁbroblasts in comparison with the background
levels (Figure 5(a)). However, the induction was very
small and not statistically signiﬁcant. On the other hand,
radiation-induced oxidative stress levels were increased in
the chronically irradiated epithelial cell lines as in one of
them, BEAS-2B we observed a statistically signiﬁcant
dose-dependent increase (Figure 5(b)).
Also, the combination of TGF-β treatment and irradi-
ation had a slight cumulative eﬀect on the 1Gy delivered
at 14mGy/h. The second cell line, HBEC-3KT, although
showing a statistically signiﬁcant induction of 8-oxo-dG
in the TGF-β treated cells, failed to respond to radiation
or to a combination of radiation and TGF-β in the same
statistically signiﬁcant manner (Figure 5(c)). This might
be explained with the diﬀerences in the genetic background
and antioxidant properties of the two cell lines [29].
CTR 0.1 Gy 1 Gy
0
50
100
150
200
250
300
350
Dose (Gy)
8-
ox
o-
dG
 (%
 o
f b
ac
kg
ro
un
d)
MRC-9
(a)
BEAS-2B
CT
R
0.
1 
G
y
1 
G
y
TG
F-
훽
0.
1 
G
y+
TG
F-
훽
1 
G
y+
TG
F-
훽
0
100
200
300
⁎ ⁎
⁎
⁎
Dose (Gy)
8-
ox
o-
dG
 (%
 o
f b
ac
kg
ro
un
d)
(b)
HBEC-3KT
CT
R
0.
1 
G
y 
1 
G
y
TG
F-
훽
0.
1 
G
y+
TG
F-
훽
1 
G
y+
TG
F-
훽
Dose (Gy)
0
100
200
300
⁎
8-
ox
o-
dG
 (%
 o
f b
ac
kg
ro
un
d)
(c)
Figure 5: 8-oxo-dG secretion in chronically irradiated MRC-9 ﬁbroblast cells (a), (b) BEAS-2B or (c) HBEC-3KT cells. The cells have been
exposed to a total of 0.1 (at 1.4mGy/h) or 1Gy (14mGy/h). Error bars—standard deviation. Statistical analysis—Student’s t-test (n = 2) (a). In
addition, the same cells were treated with the TGF-β in combination to radiation ((b) 0.1 or (c) 0.2 ng/ml) as described in Materials and
Methods. Error bars—standard deviation. ∗p < 0 05; one-way ANOVA and Tukey’s posttest (n = 2).
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4. Discussion
Based on the data for synergy between TGF-β signaling and
radiation exposure in a mouse mammary gland model [19,
37], we introduce a new mechanistic model for the lung in
which protracted exposure to low-dose radiation activates
the stromal TGF-β pathway and leads to the radiation-
induced EMT of the lung epithelial cells. We have previously
reported that low doses of gamma radiation induce oxidative
stress in a nonlinear manner [31, 32] with a peak already at
doses of about 5mGy. In our earlier studies, cells exposed
to low-dose chronic irradiation have constantly elevated oxi-
dative stress [16]. We have also shown that the main target
for radiation-induced oxidative stress is the intracellular
nucleotide pool, dNTP, where diﬀerent types of modiﬁed
dNTP can be produced, e.g., 8-oxo-dGTP. 8-oxo-dGTP
release from cells such as 8-oxo-dG can be detected as a
measurement of oxidative stress [31, 32]. In this study, the
results suggest that the low-dose rate radiation might induce
oxidative stress and that this possibly activates TGF-β and
leads to EMT-connected cell transformation, even with low
cumulative dose exposure (0.1Gy delivered at 1.4mGy/h).
We detected an increased level of the oxidative markers (8-
oxo-dG) in the culture media of the irradiated and double
treated (radiation and TGF-β) lung epithelial cells. Oxidative
stress has been previously described to play a crucial role in
the TGF-β activation [7, 31, 38]. We hypothesize that the
elevated oxidative stress and the TGF-β signaling in lung
epithelium and microenvironment are co-operating and act-
ing synergistically leading to the observed enhanced EMT-
consistent changes particularly for a dose of 1Gy in the
BEAS-2B cell line. In further studies, there should also be
considered other important and more sensitive indicators
of the TGF-β signaling activation such as p-smad 2/3 or the
Pai-1 luciferase assay [10–12].
In our study, the additional treatment of the cells with a
low concentration of TGF-β had a potentiating eﬀect on
the protracted low-dose radiation-induced EMT only when
the cumulative dose reached 1Gy for the BEAS-2B cell line.
Earlier publications by Ehrhart et al. [39] showed that TGF-
β is activated after low doses of low LET radiation in the
in vivo mouse mammary gland model. Although they found
a dose-dependent relationship for the activation of the fac-
tors, the observed eﬀects were the strongest at the lowest dose
applied (0.1Gy). We observed a similar trend in our experi-
ments for oxidative stress induction in the epithelial cell line
(BEAS-2B) at 0.1Gy. Earlier, we detected an increase in the
TGF-β levels in the MRC-9 ﬁbroblasts after acute exposure
to doses of 0.1-2Gy [34]. Other scientists have reported a sig-
niﬁcant role of TGF-β in the activation of oxidative stress
response, especially in myoﬁbroblastic cells during their
invasive transformation [40].
The activation of TGF-β signaling in the MRC-9 cells
post radiation is plausible as the molecule is one of the
main ﬁbroblast activators responsible for their transition
into myoﬁbroblasts or CAFs [36, 41]. As TGF-β is also
an important factor produced by stromal cells post irradi-
ation and involved in cancer progression, it has been
widely considered a potential therapeutic target for reduc-
ing metastases and formation of secondary cancers after
radiotherapy. Blocking its expression or application of
functional inhibitors could be a potential therapy for sec-
ondary cancer dissemination [42, 43].
We investigated the eﬀects of low-dose protracted radia-
tion in two immortalized bronchial epithelial cell lines, which
are commonly used as a model of lung epithelium. An inter-
esting ﬁnding after the protracted low-dose rate irradiations
was the detection of various EMT features in the epithelial
cells that diﬀered after irradiation compared to TGF-β
induction. For example, the analysis of the BEAS-2B cells
showed that the radiation-induced EMT was characterized
by an elongated shape with single cilium-like cytoplasmic
protrusions (Figure 1(a); 1Gy, blue arrows), while the typical
TGF-β-induced EMT phenotype was more spindle-shaped
with a well-deﬁned vimentin network (Figure 1(a); TGF-β,
white arrows). The vimentin behavior could be connected
with its functionality—the dense perinuclearly concentrated
vimentin in the nontreated cells is nonactive, while the
well-spread intermediate ﬁlament network has a crucial role
for EMT and motility in many mesenchymal type cells [44].
The additive eﬀect of radiation and TGF-βwas observed only
after the higher cumulated dose of 1Gy for both cell lines.
The role of the long protrusions in the irradiated cells is not
clear. It is possible that the cells are being transformed into
ﬁbroblasts, which described a spindle shape and are express-
ing a high level of the mesenchymal marker ﬁbronectin.
Accumulation of EMT-generated ﬁbroblasts could accelerate
the radiation-induced lung ﬁbrosis in agreement with
Guarino et al. [25] and Lee and Nelson [13]. This should be
studied further in more detail in a diﬀerent setup that
involves in vivo experiments.
In the coculturing experiments (Figure 4), we show an
increase between TGF-β vs. 0.1Gy+TGF-β and TGF-β vs.
1Gy+TGF-β EMT-related changes only in BEAS-2B cells.
The 8-oxo-dG is increasing in response to chronic irradia-
tion or to TGF-β again only in the BEAS-2B cells
(Figure 5(b)). However, the two eﬀects do not appear to
be additive except to small extent for the 1Gy+TGF-β in
the BEAS-2B cells.
In our prestudies with acute radiation exposures, some of
the classical features of the EMT were not aﬀected, although
some of the markers or phenotypic features were changed.
For example, the ZO-1 and β-catenin expression were not
aﬀected (data not shown), while the vimentin and E-
cadherin were, respectively, up- or downregulated [34]. In
the earlier study, we could not prove any clear EMT
induction with low or moderate doses of α-particles and γ-
rays. Also, no signiﬁcant additive eﬀect with radiation and
TGF-β was observed. However, the results from the current
study suggest that (1) radiation may induce partial EMT fea-
tures; (2) the radiation and particularly the protracted
radiation-induced EMT potentially have their own distin-
guishable features; (3) the combination of radiation and
TGF-β has an additive eﬀect on the EMT, but this particular
feature very likely depends on the antioxidative properties of
the cell line; and ﬁnally (4) stromal/epithelial cell cocultures
enhance the induction of EMT in one of the two cell lines
studied (BEAS-2B) suggesting that chronic in vivo exposures
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can inﬂuence precarcinogenic changes in the normal epithe-
lium via signals from the microenvironment.
In the two epithelial cell lines that have been used,
there is a clear diﬀerence in the oxidative stress product
levels post irradiation (Figures 5(b) and 5(c)). The BEAS-
2A cells are more prone to accumulation of 8-oxo-dG
than the HBEC-3KT cells. This can be connected to the
viral oncoprotein (SV40 large T antigen) immortalization
of the BEAS-2B cells [45]. While the immortalized
HBEC-3KT cells are not carcinogenic, the BEAS-2B cells
are closer in their genetic properties to tumor cells and
can undergo malignant transformations after repetitive
passaging [29]. The BEAS-2B cells are reported also to
have lower antioxidant activities, e.g., for MnSOD [45].
This is compromising their defense against free radicals,
leads to elevated extracellular 8-oxo-dG, and explains the
dose response relation for radiation-induced extracellular
8-oxo-dG presented in Figure 5(b). For HBEC-3KT, no
clear dose response relation for radiation-induced extracel-
lular 8-oxo-dG was observed (Figure 5(c)). The response
of HBEC-3KT cells at the levels of radiation-induced 8-
oxo-dG in the medium suggests that HBEC-3KT cells
might have a problem to release 8-oxo-dGTP from the
cytoplasm to the medium as similar pattern of results were
previously observed in primary ﬁbroblast knockdown in
the hMTH1 (Figure 5(c), [18]).
To our knowledge, there are no other studies describ-
ing how a chronic exposure to low doses and dose rates
ionizing radiation aﬀects both the microenvironment and
the epithelial cells. We focused on the EMT process as
one of the potential precarcinogenic stages undergone by
the epithelial cells during malignant transformation. What
we found was a partial EMT, concerning only some of the
EMT features in the epithelial cells, when they were
exposed to radiation without the stromal component. Fur-
ther, some enhanced EMT-consistent changes were moni-
tored in the TGF-β-treated and cocultured irradiated
BEAS-2B epithelial cells. These observations suggest how
the cellular transformation after low-dose radiation expo-
sures depends on the cell-to-cell interactions.
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Supplementary Figure 1: elongation in lung epithelial cell
lines BEAS-2B (A) and HBEC-3KT (B) post chronic irra-
diation with or without MRC-9 ﬁbroblasts. Elongation fac-
tor (cell length by cell diameter) was calculated manually
by ImageJ in 50 cells from each sample. Supplementary
Figure 2: immunoﬂuorescence staining of vimentin expres-
sion in lung epithelial cell line BEAS-2B cocultured with
MRC-9 ﬁbroblasts after protracted irradiation at 1.4 and
14mGy/h to 0.1 or 1Gy. Negative control without theﬁbro-
blast cells is shown on panel 0Gy/-MRC-9. Supplementary
Figure 3: comparison between the EMT markers’ expression
in monocultures of bronchial epithelial cells (A) BEAS-2B
and vimentin and (B)HBEC-3KandE-cadherin upper panels;
(A and B, lower panels) and cocultures of the same cells and
MRC-9 ﬁbroblasts, after a protracted irradiation at 1.4 and
14mGy/h to 0.1 or 1Gy. Vimentin and E-cadherin are stained
in green. The nuclei are counterstainedwith propidium iodide
(red). White arrows indicate the EMT undergone cells. Scale
bars: 20 μm. (Supplementary Materials)
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